IL6 and COVID-19: In fact, COVID-19 presents a unique and inappropriate inflammatory response, defined by decreased levels of type I and III interferons and increased production of IL-6 and chemokines (that attract/recruit T cells, NK cells, monocytes and/or macrophages and neutrophils) [23].